Track the Santhera Pharmaceuticals Holding AG stock price and the full management transaction log of the company, a listed issuer based in Switzerland. Shares are quoted on CH CH, under the oversight of SIX SER. Operating in the Health Care sector, Santhera Pharmaceuticals Holding AG has logged 3 insider filings. Market capitalisation: €168.8m. The latest transaction was reported on 25 June 2024 (Sale). Among the most active insiders: Anonymous (Executive member of the board of directors / member of senior management). Every trade is accessible without an account.
3
Insider Decl.
0
Thresholds
€313,722
2 ops.
Buy Volume
€9,423
1 ops.
Sell Volume
34Σ signal
Buys €313,722€9,423 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,432 of 26,212 companies
12.2
score / 100
Value
11
Quality
13
FCF yld-16%
Earn yld-22%
EV/EBITDA·
ROE·
Gross mgn20%
Net mgn-64%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 25 June 2024
Declarations3 total
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior management·Executives·